NCT02167256 A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02166827 Effects of a NeuroAD System, for the Treatment of Alzheimer Disease Status TERMINATED Phase NA
NCT02162264 Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice Status COMPLETED Phase N/A
NCT02158910 A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients Status COMPLETED Phase N/A
NCT02155946 Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment Status COMPLETED Phase NA
NCT02137460 Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease Status COMPLETED Phase N/A
NCT02130661 Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers Status WITHDRAWN Phase PHASE1
NCT02129348 Treatment of Psychosis and Agitation in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02127476 A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02119546 Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease Status COMPLETED Phase NA
NCT02114372 Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study Status COMPLETED Phase N/A
NCT02097056 Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT02094729 A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02089555 African American Alzheimer's Progression Markers - CSF and Neuro-Imaging Status COMPLETED Phase N/A